The implantable cardioverter defibrillator (ICD) represented a breakthrough in the prevention of sudden cardiac death. In addition to its use in secondary prevention, the indication of ICD therapy in primary prevention is also being intensively researched. A study published last year evaluated the relevance of ICD implantation in the acute phase of acute myocarditis and a registry study investigated the benefits of a wearable cardioverter defibrillator (WCD) for the prevention of sudden cardiac death in post-infarction patients.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Case report: Hiccups after ketoacidosis
Nebulized lidocaine brings relief
- Hidradenitis suppurativa: biologics reduce inflammatory processes
Treatment recommendations depend on the severity and inflammatory activity
- Dizziness as a leading symptom: new consensus paper
Current recommendations for handling in everyday practice
- Endometrial carcinoma, malignant melanoma and NSCLC in focus
Personalized mRNA and neoantigen vaccines in oncology
- Consequences for pathophysiology, clinic and therapy
The inflammatory subgroup of major depression
- Adherence of GLP1-RA
Half of patients discontinue treatment within a year
- RSV infection in adult patients at risk
Vaccination as a simple and sensible prophylaxis
- A case-based, practical overview from Canada